Latest: FDA Approves New Biosimilar for Oncology Treatment
Healthcare Business

METS-IR Predicts Cardiovascular Risk in Type 2 Diabetes

by American Journal Managed Care
0 Comments
0 Mins
Rising metabolic score for insulin resistance (METS-IR) levels strongly correlate with major cardiovascular events (MACE) and mortality in patients with type 2 diabetes (T2D), according to one study.
Tags:
American Journal Managed Care
Author

American Journal Managed Care

Previous Post
Artificial intelligence-guided ultrasound lacks sufficient accuracy for deep vein thrombosis detection
Next Post
STAT+: He was 21 when he programmed MyChart. Now he’s the president of Epic
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago